Conformis Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2023 to a ratio of 6.43, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the second quarter 2023. Average collection period, for Conformis Inc 's accounts receivable remained unchanged at 57 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 171 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. 1707.

What is Receivable Turnover Ratio?
What is Conformis Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CFMS Receivables Turnover Ratio	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter
Y / Y Receivable Change	-19.52 %	-15.65 %	7.64 %	5.92 %	7.13 %
Y / Y Revenue Change	-14.85 %	-17.45 %	12.94 %	-3.29 %	-72.86 %
Receivable Turnover Ratio (TTM)	6.43	6.36	6.38	6.28	6.42
CFMS's Total Ranking	# 1707	# 1707	# 1707	# 2237	# 1871
Accounts Receivable average collection period days	57	57	57	58	57
Seq. Receivable Change	-10.24 %	-12.49 %	3.18 %	-0.69 %	-5.93 %
Seq. Revenue Change	1.45 %	-26.31 %	26.38 %	-9.88 %	-1.65 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 79
Healthcare Sector	# 172
Overall Market	# 1707

Receivable Turnover Ratio Statistics
High	Average	Low
1.31	0.85	0.44
(Jun 30 2019)		(Jun 30 2022)

CFMS Company Profile • Back to CFMS Efficiency Comparisons • Compare CFMS Receivables Turnover Ratio to its Competitors

Financial Statements
Conformis Inc 's Accounts Receivable	$ 8 Millions	Visit CFMS's Balance sheet
Conformis Inc 's Sales TTM	$ 57 Millions	Visit CFMS's Income Statement
Sources of CFMS's Revenues		Visit CFMS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CFMS's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CFMS's Growth Rates	CFMS's Roa	CFMS's Inventory Turnover Ratio	CFMS's Dividend Comparisons
CFMS's Profitability Ratios	CFMS's Roi	CFMS's Asset Turnover Ratio	CFMS's Dividend Growth
CFMS's Valuation Ratios	CFMS's Roe	CFMS's Financial Strength Ratios	CFMS's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2023	Receivable at quarter ending Jun 30 2023
Kiniksa Pharmaceuticals International Plc	20.10	$ 280.837 Millions	$ 13.973 Millions
Lftd Partners Inc	19.38	$ 47.535 Millions	$ 2.453 Millions
Mymetics Corporation	19.24	$ 1.336 Millions	$ 0.069 Millions
Telesis Bio Inc	19.14	$ 95.322 Millions	$ 4.982 Millions
Innovage Holding Corp	19.12	$ 688.087 Millions	$ 35.990 Millions
Qhslab Inc	18.25	$ 1.295 Millions	$ 0.071 Millions
Cue Health Inc	18.24	$ 251.027 Millions	$ 13.759 Millions
Xoma Royalty Corporation	17.45	$ 4.032 Millions	$ 0.231 Millions
Capricor Therapeutics inc	17.27	$ 9.456 Millions	$ 0.548 Millions
Clearside Biomedical Inc	17.12	$ 1.618 Millions	$ 0.095 Millions
Avalo Therapeutics Inc	16.41	$ 16.963 Millions	$ 1.034 Millions
Chemed Corporation	16.35	$ 2,187.099 Millions	$ 133.800 Millions
Nektar Therapeutics	16.07	$ 87.741 Millions	$ 5.461 Millions
Ainos Inc	15.91	$ 2.874 Millions	$ 0.181 Millions
Nutriband Inc	15.67	$ 2.278 Millions	$ 0.145 Millions
Titan Pharmaceuticals Inc	15.53	$ 0.396 Millions	$ 0.026 Millions
Palvella Therapeutics Inc	15.36	$ 33.207 Millions	$ 2.161 Millions
Cano Health Inc	15.17	$ 2,978.861 Millions	$ 196.310 Millions
Neuroone Medical Technologies Corp	14.94	$ 1.279 Millions	$ 0.086 Millions
Patterson Companies Inc	14.80	$ 6,524.261 Millions	$ 440.919 Millions
Petvivo Holdings Inc	14.70	$ 0.976 Millions	$ 0.066 Millions
Ensysce Biosciences Inc	14.70	$ 2.993 Millions	$ 0.204 Millions
Invo Fertility Inc	14.58	$ 1.177 Millions	$ 0.081 Millions
Protalix Biotherapeutics inc	14.52	$ 67.463 Millions	$ 4.648 Millions
Rvl Pharmaceuticals Plc	14.22	$ 35.973 Millions	$ 2.531 Millions
C4 Therapeutics Inc	14.20	$ 16.031 Millions	$ 1.129 Millions
Thorne Healthtech Inc	14.12	$ 255.948 Millions	$ 18.120 Millions
Arrowhead Pharmaceuticals Inc	13.94	$ 256.213 Millions	$ 18.375 Millions
23andme Holding Co	13.80	$ 295.656 Millions	$ 21.428 Millions
Neptune Wellness Solutions Inc	13.72	$ 46.971 Millions	$ 3.423 Millions

Date modified: 2026-08-29T17:31:43+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.